by Uffe Ravnskov, M.D., Ph.D.
Several researchers have claimed that statin treatment prevents infections. Recently a Dutch group published an analysis of the statin trials where the authors had reported the number of infections. Not unexpectedly they didn´t find any difference between the statin groups and the controls (those who got an ineffective placebo pill).
In an editorial in the same issue of British Medical Journal, where the Dutch report was published, Beatrice Golomb commented the study. It was certainly not expected either because, as she wrote, a number of relevant factors may distort the results. One of them is the fact that among 632 statin trials, only eleven reported the number of infections, and “most authors declined to provide the omitted information when approached”. “The best evidence”, she concluded, “is that statins should not be used to forestall infection or its consequences.”
There is even evidence of the opposite. As Golomb also pointed out, low cholesterol is a risk factor for infection, and as we have a plausible mechanism to propose, we send a letter to British Medical Journal, now published as a Rapid Response.
If you sympathize with our letter you are most welcome to vote (on the right hand column). Many positive votes may possibly increase its chance to become published in the paper version as well.
Uffe Ravnskov, MD, PhD, independent investigator
President of THINCS, The International Network of Cholesterol Skeptics
Magle Stora Kyrkogata 9, 22350 Lund, Sweden
tel +46 46145022 or +46-702580416